To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Laval, Quebec's LQT Therapeutics, a new life science company focused on treating Long QT Syndrome, has raised C$1.8 million in a seed-stage financing.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination